Antimalarials May Cut Risk for Type 2 Diabetes in Lupus Patients
T2DM risk reduced by 39 percent for those with high adherence to antimalarial therapy for managing lupus
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.